1. Wohlfart S, Herth J, Böhmann MB, et al. Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality. Invest Ophthalmol Vis Sci. 2024;65(13):56. doi:10.1167/iovs.65.13.56

2. Hammer M, Britz L, Ben Böhmann M, et al. Early silicone oil opacification in the absence of emulsification is caused by an increased level of silicone dioxide. Retina. Published online October 29, 2024. doi:10.1097/IAE.0000000000004324

3. Hammer M, Herth J, Herbster L, Böhmann MB, Muuss M, Khoramnia R, et al. In Vitro Physicochemical and Pharmacokinetic Properties of Bevacizumab Dissolved in Silicone Oils Compared to Hydrogel-Substitutes and Porcine Vitreous Bodies. Gels. 2024;10(8).

4. Hammer M, Muuss M, Herbster L, Herth J, Scheuerle A, Khoramnia R, et al. Viscoelastic, Optical, and Surgical Properties of Vitreous Body Replacement Hydrogels After Aging Compared to Porcine Vitreous Bodies And Silicone Oils. Trans Vis Sci Tech. 2024 Jul 5;13(7):5.

5. Hammer M, Britz L, Schickhardt S, Munro D, Khoramnia R, Scheuerle A, et al. Straylight of explanted Silicone Oil Samples to predict Emulsification. Ophthalmology Science. 2024 May;100558.

6. Birtel J, Hammer M, Feltgen N, Pauleikhoff L, Ong AY, Geerling G, et al. Intravitreale Injektionen: Nachhaltigkeit durch Reduktion von Klinikabfall. Klin Monbl Augenheilkd. 2024 Apr 4;a-2184-9492.

7. Hammer M, Muuss M, Schickhardt S, Scheuerle A, Khoramnia R, Łabuz G, et al. Forward Light Scattering of the Vitreous Gel After Enzymatic Aging: An In Vitro Model to Study Vitreous Opacification. Invest Ophthalmol Vis Sci. 2024 Mar 29;65(3):36.

8. Hammer M, Britz L, Schickhardt S, Lieberwirth I, Munro D, Uhl P, et al. Quantification of straylight induced by silicone oil adherent to intraocular lenses of different materials. American Journal of Ophthalmology. 2023 Nov;S0002939423004889.

9. Hammer M, Herth J, Muuss M, Schickhardt S, Scheuerle A, Khoramnia R, et al. Forward Light Scattering of First to Third Generation Vitreous Body Replacement Hydrogels after Surgical Application Compared to Conventional Silicone Oils and Vitreous Body. Gels. 2023 Oct 21;9(10):837.

10. Hammer M, Schickhardt S, Munro D, Scheuerle A, Khoramnia R, Uhl P, et al. New approaches to explanting high-viscosity silicone oil in retinal surgery—polyimide cannulas vs extraction sleeves vs a luer-trocar. Int J Retin Vitr. 2023 Jul 24;9(1):43.

11. Hammer M, Schickhardt SK, Munro D, Khoramnia R, Scheuerle A, Mayer CS, et al. THE NOVEL USE OF HIGH-FLOW POLYIMIDE CANNULAS TO IMPROVE SILICONE OIL INJECTABILITY IN VITREORETINAL SURGERY. Retina. 2022 Jun;42(6):1170–5.

12. Hammer M, Schickhardt SK, Merz PR, Khoramnia R, Scheuerle AF, Mier W, et al. Intravitreal Application: Physicochemical Properties of Drugs Dissolved in Silicone Oils of Different Density in Comparison to the Porcine Vitreous Body. Pharmaceutics. 2022 Jun 28;14(7):1364.

13. Hammer M, Schickhardt S, Munro DJ, Scheuerle A, Mayer CS, Auffarth GU. Physicochemical Properties of Explanted Silicone Oil After Use as an Intraocular Tamponade. Trans Vis Sci Tech. 2022 Feb 1;11(2):3.

14. Van de Wiele VL, Hammer M, Parikh R, Feldman WB, Sarpatwari A, Kesselheim AS. Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases. Journal of Law and the Biosciences. 2022 Jan 1;9(1):lsac001.